Southfield, Michigan–(Newsfile Corp. – July 19, 2022) – A Michigan cosmetic surgery practice announced that it is working with global health authorities and FDA-designated standards bodies to innovate blockchain to make safer healthcare, starting with implantable medical devices. Michigan Cosmetic Surgeryled by board-certified plastic surgeon Dr. Mariam Awada, leads the development of the World Health Organization’s GS1 US Healthcare Initiative blockchain for FDA-regulated plastic surgery medical devices, in highlighting breast implant use cases for breast augmentation patients around the world.
Michigan cosmetic surgery logo
To view an enhanced version of this graphic, please visit:
In line with the Federal Trade Commission and the US Consumer Safety Blockchain Innovation Act, the announcement of blockchain development by Michigan Cosmetic Surgery comes at a time when multi-party collaborations have the potential to enhance US technological advancements as well as security. and the value of the healthcare supply chain. Dr. Awada worked with the leadership of the American Society of Aesthetic Plastic Surgeons and Women Plastic Surgeons to develop a blockchain based on GS1 US Healthcare Initiative standards. This prioritizes the safety and support of clinical research related to FDA-regulated devices, such as breast implants used in breast reconstruction and breast augmentation and facial fillers, and drugs that include the botulinum toxin A.
In pursuit of its goals for the industry, Michigan Cosmetic Surgery has aligned itself with the Leaders of Female Plastic Surgeons and Global Female Plastic Surgeons to improve health and safety worldwide. The practice leads multi-stakeholder collaborations and discussions that aim to improve patient safety and healthcare value while laying the foundation for modernized artificial intelligence-based research in plastic surgery.
As a member of the WHO Global Standards Blockchain, Dr. Awada shares success stories and promotes use cases of blockchain implementation that he hopes will improve the healthcare industry. health.
“Timing is critical as we are at a crossroads to spending $2 trillion on healthcare, but falling short of value and safety rankings,” Michigan Cosmetic Surgery says. “At least 15% of drugs consumed are fake due to a limited ability to authenticate medical devices. As a vendor, we strongly advocate blockchain-based patient support and automated processes to improve data and objective capabilities in real time. This is an opportunity for multi-stakeholder collaborations to achieve operational excellence while empowering providers and patients.”
Possible benefits may include cyber-secured information and new channels for reporting results of FDA-regulated medical devices, as well as enabling objective, real-time demonstration of safety and efficacy.
“This is actionable scientific insight that has the potential to guide our next generation of personalized and safer healthcare while restoring value and providing new artificial intelligence to protect patients,” the practice says.
Since 2012, Michigan Cosmetic Surgery has been a member of the US and Global Standards Healthcare Initiative and has helped define and implement standards that address regulatory and authentication issues in the supply chain with 110 members country.
“Before the past few years, we did not have an effective Web 3.0 blockchain as a general-purpose technology and foundational computing system for global multiparty communication,” said a Michigan Cosmetic Surgery spokesperson.
Michigan Cosmetic Surgery has a team of doctors, nurses, and healthcare and business professionals identifying gaps in current processes and presenting blockchain-based solutions to help overcome limitations in communicating with patients, suppliers and manufacturers. Dr. Awada’s team is an Allergan Platinum practice that handles a high volume of breast implants used for breast augmentation, breast lift, and reconstruction. “It is an honor to be supported by leadership and to be part of the team of female plastic surgeons to modernize healthcare with blockchain initiatives for patient safety in Michigan, nationwide and world.”
Michigan Cosmetic Surgery will continue to educate and lobby for blockchain development and implementation at all levels of medical development through the American Medical Association, American College of Surgeons, American Society of Aesthetic Plastic Surgeons, American Society of Plastic Surgeons and International Society of Aesthetic Plastic Surgeons. The goal of the practice is to promote education and awareness of blockchain capabilities as well as different use case benefits with a priority for long-term tracking of medical devices.
“However, in the medical field, we are not able to track the journey a breast implant takes from inception to removal. Blockchain has the potential to address gaps in total product lifecycle management and to monitor this supply chain. It is a platform that gives providers and patients the ability to communicate with each other more effectively. This could prevent gaps in the manufacturing process that have occurred during the PIP crisis in Europe and which affected hundreds of thousands of women in Europe.
The practice adds that ultimately it wants to address any issues that may still limit the health industry’s ability to perform long-term tracking of medical devices. “Blockchain is where the answer to this problem lies. We hope that by innovating this technology, we can optimize the safety of patient support before, during and after the installation of a medical device, whether it is whether it’s an orthopedic, heart or breast implant.”
Michigan Cosmetic Surgery was established by Dr. Mariam Awada in 2003 and has become one of the most recognized cosmetic surgery practices in the state. As a patient safety advocate, Dr. Awada, a Board Certified Plastic Surgeon, has twenty years of cosmetic surgery experience and is an expert in surgical center accreditation. She also has multiple MIT certificates in blockchain and business and has volunteered for the World Health Organization designated GS1 Global to create and implement global business standards that solve critical supply chain issues. .
For more information on Michigan Cosmetic Surgery, please see its website or contact:
Mariam Awada, MD FACS
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/131237